A synthetic peptide for use as a blocking control in assays to test for specificity of ALDH3 A1 antibody, Alternative Names: ALDH3A1 control peptide, ALDH3A1 antibody Blocking Peptide, Anti-ALDH3A1 Blocking Peptide, aldehyde dehydrogenase 3 family, memberA1 Blocking Peptide, ALDH3 Blocking Peptide, ALDHIII Blocking Peptide, MGC10406 Blocking Peptide, ALDH3A1, ALDHA1-3, ALDHA1 3, ALDHA1-3 Blocking Peptide, ALDHA1 3 Blocking Peptide
ALDH3A1
Reaktivität: Human, Maus
Wirt: Synthetic
BP, BI
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
ALDH3A1
(Aldehyde Dehydrogenase 3 Family, Member A1 (ALDH3A1))
Hintergrund
Aldehyde dehydrogenases oxidize various aldehydes to the corresponding acids. They are involved in the detoxification of alcohol-derived acetaldehyde and in the metabolism of corticosteroids, biogenic amines, neurotransmitters, and lipid peroxidation. The enzyme encoded by this gene forms a cytoplasmic homodimer that preferentially oxidizes aromatic and medium-chain saturated and unsaturated aldehyde substrates. It is thought to promote resistance to UV and 4-hydroxy-2-nonenal-induced oxidative damage in the cornea. The gene is located within the Smith-Magenis syndrome region on chromosome 17. Multiple alternatively spliced variants, encoding the same protein, have been identified.